IP Library Granted Patent US 12668579
Granted Patent B2
US 12668579 · App. 18/124,762 · Granted Jun 30, 2026

(3aS,4aR,5S,7aS,9R,9aR)-2,2,5,8,8,9a-hexamethyloctahydro-4H-4a,9-methanoazuleno[5,6-d][1,3]dioxole

Inventors: Sébastien March (Carouge, CH); Gerhard Brunner (Opfikon, CH); Julie Charpentier (Zurich, CH); Heinz Koch (Baeretswil, CH); Veronika Zelenay (Kemptthal, CH)
Assignee: GIVAUDAN SA
C07D317/70C11B9/0042C11B9/0076C07B2200/09C07B2200/13
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12668579
App. No.
18/124,762
Filed
Mar 22, 2023
Granted
Jun 30, 2026
Kind
B2
Art Unit
1763
USPC
512/12
Abstract

The compound (3aS,4aR,5S,7aS,9R,9aR)-2,2,5,8,8,9a-hexamethyloctahydro-4H-4a,9-methanoazuleno[5,6-d][1,3]dioxole, compositions and consumer products comprising the compound, methods of making the compound, and the various uses of the compound.

Claims (8)

1 . A fragrance ingredient comprising (3aS,4aR,5S,7aS,9R,9aR)-2,2,5,8,8,9a-hexamethyloctahydro-4H-4a,9-methanoazuleno[5,6-d][1,3]dioxole of formula (I)

2 . A fragrance composition comprising an isomeric mixture of (3aS,4aR,5S,7aS,9R,9aR)-2,2,5,8,8,9a-hexamethyloctahydro-4H-4a, 9-methanoazuleno[5,6-d][1,3]dioxole of formula (I)

and at least one compound selected from compounds of formula (II), (III), (IV) and (V)

3 . The composition of claim 2 in substantially crystalline form.

4 . The composition of claim 2 , wherein the isomeric mixture comprises a compound of formula (II).

5 . The composition of claim 4 , wherein the weight ratio of the compound of formula (I) to the compound of formula (II) ranges from 0.01:99.99 to 5:95.

6 . The composition of claim 2 , wherein the isomeric mixture does not comprise a compound of formula (III).

7 . A consumer product comprising the composition of claim 2 .